These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 18277086)

  • 1. Immune system alterations in patients with inflammatory bowel disease during remission.
    Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
    Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production in whole blood cell cultures of patients with Crohn's disease and ulcerative colitis.
    Elsässer-Beile U; von Kleist S; Gerlach S; Gallati H; Mönting JS
    J Clin Lab Anal; 1994; 8(6):447-51. PubMed ID: 7869186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
    Van Damme N; De Keyser F; Demetter P; Baeten D; Mielants H; Verbruggen G; Cuvelier C; Veys EM; De Vos M
    Clin Exp Immunol; 2001 Sep; 125(3):383-90. PubMed ID: 11531945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome.
    Raddatz D; Bockemühl M; Ramadori G
    Eur J Gastroenterol Hepatol; 2005 May; 17(5):547-57. PubMed ID: 15827446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study.
    Ardizzone S; Cassinotti A; Trabattoni D; Manzionna G; Rainone V; Bevilacqua M; Massari A; Manes G; Maconi G; Clerici M; Bianchi Porro G
    Int J Immunopathol Pharmacol; 2009; 22(1):63-71. PubMed ID: 19309553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study.
    Menegat JS; Lira-Junior R; Siqueira MA; Brito F; Carvalho AT; Fischer RG; Figueredo CM
    Arch Oral Biol; 2016 Jun; 66():141-6. PubMed ID: 26946440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
    Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
    Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
    Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
    Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
    Mazlam MZ; Hodgson HJ
    Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation.
    Naftali T; Novick D; Gabay G; Rubinstein M; Novis B
    Isr Med Assoc J; 2007 Jul; 9(7):504-8. PubMed ID: 17710779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
    Mueller C; Knoflach P; Zielinski CC
    Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of cytokines in the management of patients with inflammatory bowel disease.
    Monteleone G; MacDonald TT
    Ann Med; 2000 Nov; 32(8):552-60. PubMed ID: 11127933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Immunity Related to FOXP3
    Cho J; Kim S; Yang DH; Lee J; Park KW; Go J; Hyun CL; Jee Y; Kang KS
    J Korean Med Sci; 2018 Dec; 33(52):e336. PubMed ID: 30584414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.